Novasep eyes Japan's bioprocessing market with chromatography BD contract
In June 2015, French contract manufacturer and bioprocessing tools supplier Novasep selected AR Brown to represent its chemical and biological CMO services in Japan.
Eighteen months on and the firm has expanded the partnership, contracting AR Brown to provide services in Japan surrounding its chromatography offerings.
“AR Brown is our Japanese agent for business development once a customer orders equipment,” Alain Lamproye, president of Novasep’s Biopharma Business Unit told Biopharma-Reporter. “Novasep manages the production of the equipment and the shipping to the customer directly.”
The downstream technologies set to be supplied include Novasep’s preparative and process-scale HPLC solution Prochrom, its Supercritical Fluid Chromatography (SFC) tech Supersep, and the BioSC continuous monoclonal antibody purification system.
Having stronger representation will help Novasep capitalise from the demand in Japan for biopharma processing, which the firm says is growing due to a shift from small to large molecules in the country.
“We have succeeded in establishing our credibility as a key player in both the Chinese and Indian markets,” Lamproye said.
“We have high expectations that our skills, know-how and the quality of our equipment, in conjunction with AR Brown’s excellent market presence in the Japanese life sciences industry and reputation as a trusted partner, will significantly help our Japanese clients in achieving their market ambitions.”
